MORNINGSIDE PHARMACEUTICAL LTD — Methotrexate Importer Profile
Pharmaceutical Importer · #17 buyer for Methotrexate · $300.5K import value · 12 shipments · UNITED KINGDOM · DGFT Verified
MORNINGSIDE PHARMACEUTICAL LTD is the #17 importer of Methotrexate from India with $300.5K in import value and 12 verified shipments. MORNINGSIDE PHARMACEUTICAL LTD holds a 1.3% market share in Methotrexate imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 8 formulations shipped to 1 country.
MORNINGSIDE PHARMACEUTICAL LTD — Methotrexate Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Methotrexate to MORNINGSIDE PHARMACEUTICAL LTD?
Verified from 12 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $300.5K | 12 | 100.0% |
MORNINGSIDE PHARMACEUTICAL LTD sources Methotrexate from 1 verified Indian supplier based on 12 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does MORNINGSIDE PHARMACEUTICAL LTD Compare to Nearest Methotrexate Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $586.8K | 13 | $45.1K |
| 14 | ACCORD HEALTHCARE INC | CANADA | $535.2K | 13 | $41.2K |
| 17 | MORNINGSIDE PHARMACEUTICAL LTD ★ | UNITED KINGDOM | $455.4K | 12 | $38.0K |
| 18 | PINYO PHARMACY LTD., PART | THAILAND | $436.7K | 13 | $33.6K |
| 19 | HEMAS PHARMACEUTICALS (PVT) LTD | SRI LANKA | $435.1K | 9 | $48.3K |
MORNINGSIDE PHARMACEUTICAL LTD ranks #17 among 879 Methotrexate importers from India. Average shipment value of $38.0K compared to the market average of $10.5K. The closest competitors by value are ARROW PHARMACEUTICALS PTY LTD and ACCORD HEALTHCARE INC.
Where Does MORNINGSIDE PHARMACEUTICAL LTD Import Methotrexate To?
Destination countries from 12 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $300.5K | 12 | 100.0% |
MORNINGSIDE PHARMACEUTICAL LTD imports Methotrexate to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $300.5K.
What Methotrexate Formulations Does MORNINGSIDE PHARMACEUTICAL LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| METHOTREXATE 2.5. MG TABLETS (INV.QTY.15 | $100.0K | 2 |
| METHOTREXATE 2.5. MG TABLETS (INV.QTY.13 | $100.0K | 2 |
| METHOTREXATE 2.5 MG TABLETS (INV.QTY.16400 PACK 10 X 10S =1640000 NOS) | $50.0K | 1 |
| METHOTREXATE 2.5 MG TABLETS (INV.QTY.131040 PACK 2 X 12S =3144960 NOS) | $50.0K | 1 |
| METHOTREXATE 2.5. MG TABLETS (INV.QTY.31 | $195 | 2 |
| METHOTREXATE 2.5. MG TABLETS (INV.QTY.81 | $122 | 2 |
| METHOTREXATE 2.5 MG TABLETS (INV.QTY.22PACK 10 X 10S =2200 NOS | $75 | 1 |
| METHOTREXATE 2.5 MG TABLETS (INV.QTY.82PACK 2 X 12S = 1968 NOS) | $63 | 1 |
MORNINGSIDE PHARMACEUTICAL LTD imports 8 distinct Methotrexate formulations from India. The top formulation is METHOTREXATE 2.5. MG TABLETS (INV.QTY.15 with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Methotrexate into United Kingdom
What MORNINGSIDE PHARMACEUTICAL LTD and other importers must comply with to import Methotrexate from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Methotrexate
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Methotrexate from India and How Much Does MORNINGSIDE PHARMACEUTICAL LTD Import?
India exported $9.2M worth of Methotrexate through 3,806 shipments from 353 suppliers to 148 countries, serving 879 buyers globally. MORNINGSIDE PHARMACEUTICAL LTD imports $300.5K of this total, accounting for 1.3% of India's Methotrexate exports with 12 shipments from UNITED KINGDOM. This is verified from 12 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for MORNINGSIDE PHARMACEUTICAL LTD's Methotrexate Imports?
MORNINGSIDE PHARMACEUTICAL LTD's average Methotrexate order value is $25.0K per consignment, based on 12 shipments totaling $300.5K. MORNINGSIDE PHARMACEUTICAL LTD is based in UNITED KINGDOM and ranks #17 among all Methotrexate importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Methotrexate to MORNINGSIDE PHARMACEUTICAL LTD?
MORNINGSIDE PHARMACEUTICAL LTD sources Methotrexate from 1 verified Indian supplier: CIPLA LIMITED ($300.5K, 100.0%). This is based on 12 customs records.
How Does MORNINGSIDE PHARMACEUTICAL LTD Compare to Other Methotrexate Importers?
MORNINGSIDE PHARMACEUTICAL LTD ranks #17 among 879 Methotrexate importers from India with a 1.3% market share. The top 3 importers are ALLOGA UK LTD ($2.8M), AUROBINDO PHARMA USA., INC, ($919.5K), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ($600.0K). MORNINGSIDE PHARMACEUTICAL LTD processed 12 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Methotrexate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Methotrexate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MORNINGSIDE PHARMACEUTICAL LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MORNINGSIDE PHARMACEUTICAL LTD's capped import value divided by total capped export value for Methotrexate across all Indian exporters.
- 5.Verified Records: This page is backed by 12 individual customs records matching MORNINGSIDE PHARMACEUTICAL LTD importing Methotrexate, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 879+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Methotrexate Import Data for MORNINGSIDE PHARMACEUTICAL LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for MORNINGSIDE PHARMACEUTICAL LTD's Methotrexate imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MORNINGSIDE PHARMACEUTICAL LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
MORNINGSIDE PHARMACEUTICAL LTD × Methotrexate
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MORNINGSIDE PHARMACEUTICAL LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Methotrexate. For current order-level data, contact TransData Nexus.